Michel Obeid

9PUBLICATIONS
75CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Haematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 17, 2026
Combinatorial Delivery of Low-Dose Radiotherapy and Immunotherapy to Patients with Immune-Excluded Tumors Enhances CD8+ T-cell Functionality.

|Mar 03, 2026
Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data.

Tessa F Flores, Emily S Tonorezos, Shailender Bhatia

|Nov 14, 2024
Systematic review of immune checkpoint inhibitor-related gastrointestinal, hepatobiliary, and pancreatic adverse events.

Malek Shatila, Hao Chi Zhang, Anusha Shirwaikar Thomas

|May 01, 2024
Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma.

Victor Joo, Karim Abdelhamid, Alessandra Noto

|Dec 23, 2023
Immune checkpoint inhibitor-related myositis and myocarditis: diagnostic pitfalls and imaging contribution in a real-world, institutional case series.

Alex Vicino, Andreas F Hottinger, Sofiya Latifyan

|Jun 28, 2023
Cytokine storm complicated by cardiogenic shock induced by anti-HER2 therapies.

Rita Godinho, Alessandra Noto, Craig Fenwick

Pageof 2

Frequent Collaborators

3 joint publications

John O Prior

3 joint publications

Yinghong Wang

2 joint publications

Niklaus Schaefer

2 joint publications

Marc S Ernstoff